Overactive bladder: modern treatment options
Overactive bladder is common and treatable. How bladder training works, antimuscarinics vs mirabegron, and the options when tablets are not enough.
Overactive bladder — the sudden, hard-to-defer urge to pee, often with more than eight trips a day and broken nights — is common, treatable and heavily under-reported. Treatment climbs a ladder. First, six weeks of bladder training with a few fluid changes, which genuinely helps most people. Then medicines: antimuscarinic tablets such as oxybutynin, tolterodine and solifenacin, or mirabegron (branded Betmiga), a newer tablet that calms the bladder through a different receptor and sidesteps the dry mouth the older tablets cause. For the minority still struggling after that, specialist options — from Botox injections to nerve stimulation — have good success rates. Nobody should be planning life around a bladder before trying the ladder.
What overactive bladder is — and is not
Overactive bladder is a symptom cluster: urgency (the headline symptom), daytime frequency, waking at night to pass urine, with or without leaks on the way to the toilet. It usually reflects a bladder muscle that contracts during filling, when it should stay quiet. It is not the same as stress incontinence — leaking with coughs, sneezes or exercise — which is a pelvic floor problem treated differently; many women have a mixture, and the dominant symptom guides treatment. Assessment first rules out mimics: urine infection, poorly controlled diabetes, bladder stones. In men, an enlarging prostate produces overlapping symptoms and changes the medication conversation.
Start here: bladder training and fluid habits
Bladder training rebuilds the bladder's tolerance of filling. Using a three-day diary as your baseline, you defer each urge slightly — distraction, a firm pelvic floor squeeze, standing still until it passes — stretching the interval between visits by ten to fifteen minutes each week until three-to-four-hour gaps feel normal. Run properly for six weeks or more, trials show it rivals medication for many people, without side effects. Fluid habits matter alongside: caffeine is the single biggest culprit (a strict two-week caffeine-free trial is genuinely informative), alcohol and fizzy drinks irritate some bladders, and — counterintuitively — restricting fluid too hard backfires, because concentrated urine irritates the bladder lining. For night-time symptoms, shift most fluid earlier in the evening. And if you carry extra weight, even modest loss measurably reduces urgency and leaks.
Antimuscarinics: oxybutynin, tolterodine, solifenacin
The established family. They block the acetylcholine signalling that fires involuntary bladder contractions, and they work — but the same receptor serves the salivary glands and bowel, hence dry mouth, constipation and occasionally blurred vision. Modern practice prefers modified-release versions or newer agents, and gives any tablet a proper four-week trial before judging it. One caution has hardened in recent years: long-term anticholinergic load is linked to cognitive decline in older adults, and UK guidance specifically avoids immediate-release oxybutynin in frail older people — worth raising if an older relative has been on it for years.
Mirabegron: the beta-3 alternative
Mirabegron relaxes the bladder muscle during filling by stimulating beta-3 receptors — a different mechanism entirely, so no dry mouth and no anticholinergic concerns. Its efficacy is broadly comparable to the antimuscarinics. The check it demands is blood pressure, which it can raise: readings before and during treatment, and uncontrolled hypertension rules it out. In UK practice it is used when antimuscarinics fail or their side effects bite, and when anticholinergic burden matters; specialists sometimes combine it with solifenacin when neither alone is enough.
Choosing between them
There is no universal winner — on average the tablets perform similarly, so the choice hangs on trade-offs. Dry mouth intolerable? Mirabegron has the case. Blood pressure high? An antimuscarinic. Older, or already on other anticholinergic medicines? Mirabegron again. Constipation-prone? Think twice about oxybutynin. A three-day diary before and after each trial makes success measurable rather than a guess — and switching after a fair four-week trial is normal practice, not failure.
When tablets are not enough
The ladder keeps going, with strong evidence at each rung: botulinum toxin injected into the bladder wall calms it for six to twelve months per treatment (with a small risk of needing temporary self-catheterisation), percutaneous tibial nerve stimulation modulates bladder nerves through a fine needle near the ankle over weekly sessions, and sacral neuromodulation implants a small device that steadies the bladder's nerve supply long term. Surgery is a rare last resort. The message is simply that nobody should settle for mapping every journey by its toilets.
See someone in person if
Blood in your urine, pain on passing urine, recurrent infections, fever, new numbness or other neurological symptoms, or — in men — a weak stream with a feeling of incomplete emptying all need in-person assessment first rather than an online start.
Frequently asked questions
How long before the tablets work?
Some effect often appears within a fortnight; judge properly at four weeks, diary in hand. Bladder training continues alongside — the combination beats either alone.
Is caffeine really that important?
For urgency, often yes. Caffeine both irritates the bladder and increases urine production. A strict two-week trial without it — watching for it hiding in tea, cola and some cold remedies — tells you whether it is one of your levers.
Betmiga or oxybutynin — which is better?
Neither, on average: efficacy is similar and the difference is side effects. Oxybutynin brings dry mouth and constipation and is avoided in frail older adults; mirabegron needs blood pressure checks. The right answer comes from your history, not a league table.
Will I need treatment forever?
Not necessarily. Bladder training gains often persist, and a planned withdrawal of tablets after six to twelve good months is a reasonable test of whether retraining holds. Some people do stay on long-term treatment — that is safe with routine review.
If urgency is running your diary, you can check your eligibility for overactive bladder treatment online — a UK clinician reviews your symptoms and history before any treatment is prescribed.
Related reading
More clinically reviewed articles: all health guides.